Comparative Pharmacology
Head-to-head clinical analysis: ASCOR versus FOLIC ACID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ASCOR versus FOLIC ACID.
ASCOR vs FOLIC ACID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ascorbic acid (vitamin C) acts as an antioxidant and a cofactor for several enzymes involved in collagen synthesis, carnitine biosynthesis, and neurotransmitter synthesis. It facilitates iron absorption from the gastrointestinal tract and participates in immune function.
Folic acid is a synthetic form of folate, a water-soluble B vitamin. It is reduced to dihydrofolate (DHF) and then to tetrahydrofolate (THF) via dihydrofolate reductase (DHFR). THF serves as a cofactor for one-carbon transfer reactions essential for purine and thymidine synthesis (DNA replication), amino acid metabolism (e.g., homocysteine remethylation to methionine), and other methylation reactions.
1 tablet (75 mg) orally once daily for antiplatelet effect; for acute coronary syndrome: initial dose 300 mg orally, then 75 mg orally once daily.
Oral or intramuscular/subcutaneous injection: 400-800 mcg daily for general supplementation; 1-5 mg daily for folate deficiency; 5-15 mg daily for megaloblastic anemia.
None Documented
None Documented
Clinical Note
moderateFolic acid + Teriflunomide
"The serum concentration of Teriflunomide can be increased when it is combined with Folic acid."
Clinical Note
moderateTiaprofenic acid + Folic acid
"The therapeutic efficacy of Folic acid can be decreased when used in combination with Tiaprofenic acid."
Clinical Note
moderateCarprofen + Folic acid
"The therapeutic efficacy of Folic acid can be decreased when used in combination with Carprofen."
Clinical Note
moderateCyproterone acetate + Folic acid
Terminal elimination half-life is 8-12 hours in patients with normal renal function; prolonged to 24-48 hours in renal impairment, requiring dose adjustment.
Terminal elimination half-life is approximately 0.7 hours (range 0.5-1.0 h) for folic acid; the active metabolite (5-MTHF) has a longer half-life of about 3-4 hours.
Renal: 70-90% (as unchanged drug and metabolites), biliary/fecal: minor (<10%)
Primarily renal (urinary) as intact folic acid and metabolites, accounting for 80-90% of the excreted dose; fecal elimination via bile is minor (<10%).
Category C
Category A/B
Vitamin
Vitamin
"The serum concentration of Folic acid can be decreased when it is combined with Cyproterone acetate."